CD8+ T-cell priming and boosting: More antigen-presenting DC, or more antigen per DC?

Cancer Immunology, Immunotherapy

Volumn 62, Issue 12, 2013, Pages 1769-1780

  Schaft, Niels ^a   Wellner, Verena ^a   Wohn, Christian ^a,b   Schuler, Gerold ^a   Dörrie, Jan ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antigen presentation; Dendritic cells; Electroporation; Lipofection; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MELAN A;

ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ELECTROPORATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; LIMIT OF DETECTION; PHENOTYPE; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ELECTROPORATION; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; MART-1 ANTIGEN; MONOCYTES; PEPTIDE FRAGMENTS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84890321725     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1481-z     Document Type: Article

References (34)

1. Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12:265-277
2. Lesterhuis WJ, Aarntzen EH, de Vries IJ, Schuurhuis DH, Figdor CG, Adema GJ, Punt CJ (2008) Dendritic cell vaccines in melanoma: from promise to proof? Crit Rev Oncol Hematol 66:118-134
3. Van Tendeloo VF, Ponsaerts P, Berneman ZN (2007) mRNA-based gene transfer as a tool for gene and cell therapy. Curr Opin Mol Ther 9:423-431
4. Schaft N, Dorrie J, Thumann P, Beck VE, Muller I, Schultz ES, Kampgen E, Dieckmann D, Schuler G (2005) Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. J Immunol 174:3087-3097
5. Frankenberger B, Schendel DJ (2012) Third generation dendritic cell vaccines for tumor immunotherapy. Eur J Cell Biol 91:53-58
6. Wilgenhof S, Van Nuffel AM, Corthals J, Heirman C, Tuyaerts S, Benteyn D, De Coninck A, Van RI, Verfaillie G, Vandeloo J, Bonehill A, Thielemans K, Neyns B (2011) Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma. J Immunother 34:448-456
7. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98:49-56
8. Erdmann M, Dorrie J, Schaft N, Strasser E, Hendelmeier M, Kampgen E, Schuler G, Schuler-Thurner B (2007) Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection. J Immunother 30:663-674
9. Michiels A, Tuyaerts S, Bonehill A, Corthals J, Breckpot K, Heirman C, Van Meirvenne S, Dullaers M, Allard S, Brasseur F, Van Der BP, Thielemans K (2005) Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines. Gene Ther 12:772-782
10. Michiels A, Tuyaerts S, Bonehill A, Heirman C, Corthals J, Thielemans K (2008) Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination. Methods Mol Biol 423:155-163
11. Schuurhuis DH, Fu N, Ossendorp F, Melief CJ (2006) Ins and outs of dendritic cells. Int Arch Allergy Immunol 140:53-72
12. Okano K, Fukui M, Suehiro Y, Hamanaka Y, Imai K, Hinoda Y (2003) Evaluation of an mRNA lipofection procedure for human dendritic cells and induction of cytotoxic T lymphocytes against enhanced green fluorescence protein. Tumour Biol 24:317-324
13. Liao X, Li Y, Bonini C, Nair S, Gilboa E, Greenberg PD, Yee C (2004) Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes. Mol Ther 9:757-764
14. Yu H, Babiuk LA, van Drunen Littel-van den Hurk S (2007) Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. Vaccine 25:1701-1711
15. Dorrie J, Schaft N, Muller I, Wellner V, Schunder T, Hanig J, Oostingh GJ, Schon MP, Robert C, Kampgen E, Schuler G (2008) Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes. Cancer Immunol Immunother 57:467-477
16. Melhem NM, Gleason SM, Liu XD, Barratt-Boyes SM (2008) High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA. Clin Vaccine Immunol 15:1337-1344
17. Gilboa E (2007) DC-based cancer vaccines. J Clin Invest 117:1195-1203
18. Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E (1998) Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 16:364-369
19. Grunebach F, Muller MR, Nencioni A, Brossart P (2003) Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther 10:367-374
20. Valmori D, Fonteneau JF, Lizana CM, Gervois N, Lienard D, Rimoldi D, Jongeneel V, Jotereau F, Cerottini JC, Romero P (1998) Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J Immunol 160:1750-1758
21. Schreurs MW, Eggert AA, de Boer AJ, Vissers JL, van Hall T, Offringa R, Figdor CG, Adema GJ (2000) Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Cancer Res 60:6995-7001
22. Wilde S, Sommermeyer D, Frankenberger B, Schiemann M, Milosevic S, Spranger S, Pohla H, Uckert W, Busch DH, Schendel DJ (2009) Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity. Blood 114:2131-2139
23. Bullock TN, Mullins DW, Engelhard VH (2003) Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J Immunol 170:1822-1829
24. Schaft N, Dorrie J, Muller I, Beck V, Baumann S, Schunder T, Kampgen E, Schuler G (2006) A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes. Cancer Immunol Immunother 55:1132-1141
25. Heiser A, Dahm P, Yancey DR, Maurice MA, Boczkowski D, Nair SK, Gilboa E, Vieweg J (2000) Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol 164:5508-5514
26. Birkholz K, Hofmann C, Hoyer S, Schulz B, Harrer T, Kampgen E, Schuler G, Dorrie J, Schaft N (2009) A fast and robust method to clone and functionally validate T-cell receptors. J Immunol Methods 346:45-54
27. Melhem NM, Liu XD, Boczkowski D, Gilboa E, Barratt-Boyes SM (2007) Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag. Eur J Immunol 37:2164-2173
28. Boudreau JE, Bonehill A, Thielemans K, Wan Y (2011) Engineering dendritic cells to enhance cancer immunotherapy. Mol Ther 19:841-853
29. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515-3519
30. Landi A, Babiuk LA, van Drunen Littel-van den Hurk S (2007) High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol 82:849-860
31. Bonehill A, Heirman C, Tuyaerts S, Michiels A, Breckpot K, Brasseur F, Zhang Y, Van Der BP, Thielemans K (2004) Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. J Immunol 172:6649-6657
32. Strobel I, Berchtold S, Gotze A, Schulze U, Schuler G, Steinkasserer A (2000) Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. Gene Ther 7(23):2028-2035
33. Van Tendeloo VF, Snoeck HW, Lardon F, Vanham GL, Nijs G, Lenjou M et al (1998) Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells. Gene Ther 5(5):700-707
34. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C et al (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98(1):49-56